NCT03760042View on ClinicalTrials.gov

Study To Assess Local Tolerability of Crisaborole 2% Ointment and Vehicle Ointment In Healthy Participants Using Subject-reported Assessments and Objective Measurements

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

November 14, 2018

Primary Completion Date

April 15, 2019

Study Completion Date

April 15, 2019

Conditions
Healthy
Interventions
DRUG

Within-Subject Active vs Placebo Topical Applications

Crisaborole 2% ointment (right side) and Placebo vehicle ointment (left side)

DRUG

Within-Subject Active vs. Placebo Topical Applications

Crisaborole 2% ointment (left side) and Placebo vehicle ointment (right side)

Trial Locations (1)

06511

New Haven Clinical Research Unit, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY